AU2001235669A1 - Use of xanthine derivatives for preparing a medicine for preventing and treatingosteoporosis - Google Patents

Use of xanthine derivatives for preparing a medicine for preventing and treatingosteoporosis

Info

Publication number: AU2001235669A1
Authority: AU; Australia
Prior art keywords: medicine; preparing; preventing; treatingosteoporosis; xanthine derivatives
Prior art date: 2000-02-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001235669A

Other languages

English (en)

Inventor

Gunter Johannes Billen

Yamina Bouali

Yusuke Satoh

Jean-Paul Vevert

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Aventis Pharma SA

Original Assignee

Aventis Pharma SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-15

Filing date

2001-02-14

Publication date

2001-08-27

2001-02-14 Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA

2001-08-27 Publication of AU2001235669A1 publication Critical patent/AU2001235669A1/en

Status Abandoned legal-status Critical Current

Links

LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title abstract 2
239000003814 drug Substances 0.000 title abstract 2
229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 title 1
208000001132 Osteoporosis Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH

Landscapes

Health & Medical Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Rheumatology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Immunology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AU2001235669A 2000-02-15 2001-02-14 Use of xanthine derivatives for preparing a medicine for preventing and treatingosteoporosis Abandoned AU2001235669A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0001846A FR2804867B1 (fr)	2000-02-15	2000-02-15	Application de derives de xanthine pour la preparation d'un medicament destine a la prevention ou au traitement de l'osteoporose
FR0001846		2000-02-15
PCT/FR2001/000421 WO2001060372A2 (fr)	2000-02-15	2001-02-14	Application de derives de xanthine pour la preparation d'un medicament destine a la prevention ou au traitement de l'osteoporose

Publications (1)

Publication Number	Publication Date
AU2001235669A1 true AU2001235669A1 (en)	2001-08-27

Family

ID=8847005

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001235669A Abandoned AU2001235669A1 (en)	2000-02-15	2001-02-14	Use of xanthine derivatives for preparing a medicine for preventing and treatingosteoporosis

Country Status (9)

Country	Link
EP (1)	EP1263444B1 (fr)
AT (1)	ATE300304T1 (fr)
AU (1)	AU2001235669A1 (fr)
DE (1)	DE60112253T2 (fr)
DK (1)	DK1263444T3 (fr)
ES (1)	ES2242731T3 (fr)
FR (1)	FR2804867B1 (fr)
PT (1)	PT1263444E (fr)
WO (1)	WO2001060372A2 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69332634T2 (de) *	1992-03-04	2003-05-08	Cell Therapeutics, Inc.	Enantiomere hydroxylierte xanthinverbindungen
DE19540798A1 (de) *	1995-11-02	1997-05-07	Hoechst Ag	Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel
JPH09169665A (ja) *	1995-12-21	1997-06-30	Kenichi Miyamoto	骨粗鬆症治療剤
SI0812844T1 (en) *	1996-06-07	2003-02-28	Hoechst Aktiengesellschaft	Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
JPH1192379A (ja) *	1997-07-24	1999-04-06	Kunio Takaoka	骨疾患の予防または治療剤

2000
- 2000-02-15 FR FR0001846A patent/FR2804867B1/fr not_active Expired - Fee Related
2001
- 2001-02-14 AT AT01907785T patent/ATE300304T1/de active
- 2001-02-14 EP EP01907785A patent/EP1263444B1/fr not_active Expired - Lifetime
- 2001-02-14 WO PCT/FR2001/000421 patent/WO2001060372A2/fr active IP Right Grant
- 2001-02-14 PT PT01907785T patent/PT1263444E/pt unknown
- 2001-02-14 AU AU2001235669A patent/AU2001235669A1/en not_active Abandoned
- 2001-02-14 ES ES01907785T patent/ES2242731T3/es not_active Expired - Lifetime
- 2001-02-14 DK DK01907785T patent/DK1263444T3/da active
- 2001-02-14 DE DE60112253T patent/DE60112253T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60112253T2 (de)	2006-06-01
ES2242731T3 (es)	2005-11-16
WO2001060372A2 (fr)	2001-08-23
EP1263444B1 (fr)	2005-07-27
DK1263444T3 (da)	2005-11-14
FR2804867A1 (fr)	2001-08-17
DE60112253D1 (de)	2005-09-01
FR2804867B1 (fr)	2002-09-20
WO2001060372A3 (fr)	2002-04-11
PT1263444E (pt)	2005-10-31
EP1263444A2 (fr)	2002-12-11
ATE300304T1 (de)	2005-08-15

Similar Documents

Publication	Publication Date	Title
WO2001046200A8 (fr)	2002-02-28	Nouveaux derives de piperidine et de piperazine
AU5242000A (en)	2001-01-22	Nematicidal trifluorobutenes
SE9904505D0 (sv)	1999-12-09	Novel compounds
MY132671A (en)	2007-10-31	Substituted 6,6-hetero-bicyclic derivatives
MXPA03006093A (es)	2005-02-14	Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
WO2001019829A3 (fr)	2001-09-27	Pyrazolopyrimidines en tant qu'agents therapeutiques
WO2001066564A3 (fr)	2002-01-03	Inhibiteurs de gamma-sécrétase
YU6303A (sh)	2006-03-03	Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
AU2001264474A1 (en)	2001-12-17	Admantane derivatives
AU2002239348A1 (en)	2002-06-24	Pyrazolopyridine derivatives
MXPA03008215A (es)	2004-01-29	Inhibidores de integrina alfa v beta 6.
AU2002213421A1 (en)	2002-04-15	Condensed pyridoindole derivatives
MXPA03010761A (es)	2004-03-02	Combinaciones farmaceuticas.
GEP20074045B (en)	2007-02-26	(4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
GB0109122D0 (en)	2001-05-30	Novel compounds
IL150061A0 (en)	2002-12-01	Purine derivatives
MY133112A (en)	2007-10-31	3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MXPA05006889A (es)	2006-04-07	Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
AU2002213419A1 (en)	2002-04-15	Condensed pyridoindole derivatives
AU2001263278A1 (en)	2002-01-08	Cyclic gmp-specific phosphodiesterase inhibitors
MXPA02004441A (es)	2004-09-10	Derivados de isoxazol como inhibidores de la fosfodiesterasa.
WO2001010860A3 (fr)	2001-08-23	Derives de quinazolinone et d'azaquinazolinone
AU2001296699A1 (en)	2002-05-21	Condensed pyrazindione derivatives as pde inhibitors
AU2002211493A1 (en)	2002-05-15	Indole derivatives as pde5-inhibitors
WO2001060343A3 (fr)	2002-05-30	Utilisation d'acide 2-methyl-thiazolidin-2,4-dicarboxylique (2-mtdc) et/ou de ses sels physiologiquement compabibles pour le traitement et/ou la prevention de cancers